{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:18:08Z","timestamp":1778599088133,"version":"3.51.4"},"publisher-location":"Cham","reference-count":81,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032177742","type":"print"},{"value":"9783032177759","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-3-032-17775-9_6","type":"book-chapter","created":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T12:13:21Z","timestamp":1771157601000},"page":"113-127","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HPV Type Replacement After HPV Vaccination"],"prefix":"10.1007","author":[{"given":"Elizabeth M.","family":"Anderson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred J.","family":"Saah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph E.","family":"Tota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"6_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00059","volume":"9","author":"A Ahrlund-Richter","year":"2019","unstructured":"Ahrlund-Richter A, Cheng L, Hu YOO, Svensson M, Pennhag AAL, Ursu RG et al (2019) Changes in cervical human papillomavirus (HPV) prevalence at a youth clinic in Stockholm, Sweden, a decade after the introduction of the HPV vaccine. Front Cell Infect Microbiol 9:59","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"6_CR2","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/0966-842X(94)90602-5","volume":"2","author":"H-U Bernard","year":"1994","unstructured":"Bernard H-U (1994) Coevolution of papiliomaviruses with human populations. Trends Microbiol 2(4):140\u2013143","journal-title":"Trends Microbiol"},{"issue":"5","key":"6_CR3","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/ijc.21655","volume":"118","author":"HU Bernard","year":"2006","unstructured":"Bernard HU, Calleja-Macias IE, Dunn ST (2006) Genome variation of human papillomavirus types: phylogenetic and medical implications. Int J Cancer 118(5):1071\u20131076","journal-title":"Int J Cancer"},{"key":"6_CR4","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268823000122","volume":"151","author":"M Bonneault","year":"2023","unstructured":"Bonneault M, Delarocque-Astagneau E, Flauder M, Bogaards JA, Guillemot D, Opatowski L et al (2023) Ability of epidemiological studies to monitor HPV post-vaccination dynamics: a simulation study. Epidemiol Infect 151:e31","journal-title":"Epidemiol Infect"},{"issue":"3","key":"6_CR5","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"6_CR6","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1086\/374624","volume":"187","author":"AB Brueggemann","year":"2003","unstructured":"Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, Spratt BG (2003) Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis 187(9):1424\u20131432","journal-title":"J Infect Dis"},{"issue":"8","key":"6_CR7","doi-asserted-by":"publisher","first-page":"e1115","DOI":"10.1016\/S2214-109X(22)00241-8","volume":"10","author":"L Bruni","year":"2022","unstructured":"Bruni L, Serrano B, Roura E, Alemany L, Cowan M, Herrero R et al (2022) Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis. Lancet Glob Health 10(8):e1115\u2013e1e27","journal-title":"Lancet Glob Health"},{"issue":"1\u20132","key":"6_CR8","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.virol.2013.07.018","volume":"445","author":"RD Burk","year":"2013","unstructured":"Burk RD, Harari A, Chen Z (2013) Human papillomavirus genome variants. Virology 445(1\u20132):232\u2013243","journal-title":"Virology"},{"issue":"32","key":"6_CR9","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1016\/j.vaccine.2014.05.041","volume":"32","author":"ET Callegari","year":"2014","unstructured":"Callegari ET, Tabrizi SN, Pyman J, Saville M, Cornall AM, Brotherton JM et al (2014) How best to interpret mixed human papillomavirus genotypes in high-grade cervical intraepithelial neoplasia lesions. Vaccine 32(32):4082\u20134088","journal-title":"Vaccine"},{"issue":"1","key":"6_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-2945-8","volume":"18","author":"F Carozzi","year":"2018","unstructured":"Carozzi F, Puliti D, Ocello C, Anastasio PS, Moliterni EA, Perinetti E et al (2018) Monitoring vaccine and non-vaccine HPV type prevalence in the post-vaccination era in women living in the Basilicata region, Italy. BMC Infect Dis 18(1):38","journal-title":"BMC Infect Dis"},{"issue":"1","key":"6_CR11","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/ijc.21299","volume":"118","author":"PK Chan","year":"2006","unstructured":"Chan PK, Cheung TH, Tam AO, Lo KW, Yim SF, Yu MM et al (2006) Biases in human papillomavirus genotype prevalence assessment associated with commonly used consensus primers. Int J Cancer 118(1):243\u2013245","journal-title":"Int J Cancer"},{"issue":"10","key":"6_CR12","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1158\/1055-9965.EPI-05-0465","volume":"14","author":"AK Chaturvedi","year":"2005","unstructured":"Chaturvedi AK, Myers L, Hammons AF, Clark RA, Dunlap K, Kissinger PJ et al (2005) Prevalence and clustering patterns of human papillomavirus genotypes in multiple infections. Cancer Epidemiol Biomarkers Prev 14(10):2439\u20132445","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"6_CR13","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1093\/infdis\/jiq139","volume":"203","author":"AK Chaturvedi","year":"2011","unstructured":"Chaturvedi AK, Katki HA, Hildesheim A, Rodriguez AC, Quint W, Schiffman M et al (2011) Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease. J Infect Dis 203(7):910\u2013920","journal-title":"J Infect Dis"},{"issue":"3","key":"6_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/ng.2895","volume":"46","author":"C Chewapreecha","year":"2014","unstructured":"Chewapreecha C, Harris SR, Croucher NJ, Turner C, Marttinen P, Cheng L et al (2014) Dense genomic sampling identifies highways of pneumococcal recombination. Nat Genet 46(3):305\u2013309","journal-title":"Nat Genet"},{"issue":"23","key":"6_CR15","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.1016\/j.vaccine.2012.03.065","volume":"30","author":"YH Choi","year":"2012","unstructured":"Choi YH, Chapman R, Gay N, Jit M (2012) Potential overestimation of HPV vaccine impact due to unmasking of non-vaccine types: quantification using a multi-type mathematical model. Vaccine 30(23):3383\u20133388","journal-title":"Vaccine"},{"issue":"7\u20138","key":"6_CR16","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1080\/21645515.2018.1564438","volume":"15","author":"C Covert","year":"2019","unstructured":"Covert C, Ding L, Brown D, Franco EL, Bernstein DI, Kahn JA (2019) Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction. Hum Vaccin Immunother 15(7\u20138):1962\u20131969","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"6_CR17","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1128\/IAI.01775-05","volume":"75","author":"S Dawid","year":"2007","unstructured":"Dawid S, Roche AM, Weiser JN (2007) The blp bacteriocins of Streptococcus pneumoniae mediate intraspecies competition both in vitro and in vivo. Infect Immun 75(1):443\u2013451","journal-title":"Infect Immun"},{"issue":"2","key":"6_CR18","doi-asserted-by":"publisher","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","volume":"8","author":"C de Martel","year":"2020","unstructured":"de Martel C, Georges D, Bray F, Ferlay J, Clifford GM (2020) Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health 8(2):e180\u2013e190","journal-title":"Lancet Glob Health"},{"key":"6_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.coviro.2019.06.006","volume":"39","author":"S de Sanjose","year":"2019","unstructured":"de Sanjose S, Brotons M, LaMontagne DS, Bruni L (2019) Human papillomavirus vaccine disease impact beyond expectations. Curr Opin Virol 39:16\u201322","journal-title":"Curr Opin Virol"},{"issue":"1","key":"6_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","volume":"324","author":"EM de Villiers","year":"2004","unstructured":"de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H (2004) Classification of papillomaviruses. Virology 324(1):17\u201327","journal-title":"Virology"},{"key":"6_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100293","volume":"22","author":"M Demarco","year":"2020","unstructured":"Demarco M, Hyun N, Carter-Pokras O, Raine-Bennett TR, Cheung L, Chen X et al (2020) A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs. EClinicalMedicine 22:100293","journal-title":"EClinicalMedicine"},{"issue":"10197","key":"6_CR22","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","volume":"394","author":"M Drolet","year":"2019","unstructured":"Drolet M, Benard E, Perez N, Brisson M, Group HPVVIS (2019) Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet 394(10197):497\u2013509","journal-title":"Lancet"},{"issue":"7","key":"6_CR23","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1128\/JCM.00840-12","volume":"50","author":"C Eklund","year":"2012","unstructured":"Eklund C, Forslund O, Wallin KL, Zhou T, Dillner J, Network WHOHPL (2012) The 2010 global proficiency study of human papillomavirus genotyping in vaccinology. J Clin Microbiol 50(7):2289\u20132298","journal-title":"J Clin Microbiol"},{"issue":"10","key":"6_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0223612","volume":"14","author":"E Enerly","year":"2019","unstructured":"Enerly E, Flingtorp R, Christiansen IK, Campbell S, Hansen M, Myklebust TA et al (2019) An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway. PLoS One 14(10):e0223612","journal-title":"PLoS One"},{"issue":"12","key":"6_CR25","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1093\/infdis\/jiy432","volume":"218","author":"B Feiring","year":"2018","unstructured":"Feiring B, Laake I, Christiansen IK, Hansen M, Stalcrantz J, Ambur OH et al (2018) Substantial decline in prevalence of vaccine-type and nonvaccine-type human papillomavirus (HPV) in vaccinated and unvaccinated girls 5 years after implementing HPV vaccine in Norway. J Infect Dis 218(12):1900\u20131910","journal-title":"J Infect Dis"},{"key":"6_CR26","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.rmed.2017.03.030","volume":"126","author":"HR Fortes","year":"2017","unstructured":"Fortes HR, von Ranke FM, Escuissato DL, Araujo Neto CA, Zanetti G, Hochhegger B et al (2017) Recurrent respiratory papillomatosis: a state-of-the-art review. Respir Med 126:116\u2013121","journal-title":"Respir Med"},{"issue":"6","key":"6_CR27","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1086\/597071","volume":"199","author":"SM Garland","year":"2009","unstructured":"Garland SM, Steben M, Sings HL, James M, Lu S, Railkar R et al (2009) Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis 199(6):805\u2013814","journal-title":"J Infect Dis"},{"key":"6_CR28","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.ebiom.2019.04.021","volume":"43","author":"RA Gladstone","year":"2019","unstructured":"Gladstone RA, Lo SW, Lees JA, Croucher NJ, van Tonder AJ, Corander J et al (2019) International genomic definition of pneumococcal lineages, to contextualise disease, antibiotic resistance and vaccine impact. EBioMedicine 43:338\u2013346","journal-title":"EBioMedicine"},{"issue":"12","key":"6_CR29","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1002\/ijc.33169","volume":"147","author":"P Gray","year":"2020","unstructured":"Gray P, Kann H, Pimenoff VN, Adhikari I, Eriksson T, Surcel HM et al (2020) Long-term follow-up of human papillomavirus type replacement among young pregnant Finnish females before and after a community-randomised HPV vaccination trial with moderate coverage. Int J Cancer 147(12):3511\u20133522","journal-title":"Int J Cancer"},{"issue":"1","key":"6_CR30","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/bjc.1989.236","volume":"60","author":"L Gustafsson","year":"1989","unstructured":"Gustafsson L, Adami HO (1989) Natural history of cervical neoplasia: consistent results obtained by an identification technique. Br J Cancer 60(1):132\u2013141","journal-title":"Br J Cancer"},{"key":"6_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000355952","volume":"45","author":"A Harari","year":"2014","unstructured":"Harari A, Chen Z, Burk RD (2014) Human papillomavirus genomics: past, present and future. Curr Probl Dermatol 45:1\u201318","journal-title":"Curr Probl Dermatol"},{"issue":"2","key":"6_CR32","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1080\/21645515.2015.1118593","volume":"12","author":"WP Hausdorff","year":"2016","unstructured":"Hausdorff WP, Hanage WP (2016) Interim results of an ecological experiment \u2013 conjugate vaccination against the pneumococcus and serotype replacement. Hum Vaccin Immunother 12(2):358\u2013374","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"6_CR33","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/infdis\/169.2.235","volume":"169","author":"A Hildesheim","year":"1994","unstructured":"Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T et al (1994) Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 169(2):235\u2013240","journal-title":"J Infect Dis"},{"key":"6_CR34","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/oxfordjournals.jncimonographs.a003487","volume":"31","author":"T Iftner","year":"2003","unstructured":"Iftner T, Villa LL (2003) Chapter 12: Human papillomavirus technologies. J Natl Cancer Inst Monogr 31:80\u201388","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"21","key":"6_CR35","doi-asserted-by":"publisher","first-page":"10630","DOI":"10.1158\/0008-5472.CAN-06-1057","volume":"66","author":"S Kjaer","year":"2006","unstructured":"Kjaer S, Hogdall E, Frederiksen K, Munk C, van den Brule A, Svare E et al (2006) The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period. Cancer Res 66(21):10630\u201310636","journal-title":"Cancer Res"},{"issue":"10","key":"6_CR36","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1093\/jnci\/djab080","volume":"113","author":"SK Kjaer","year":"2021","unstructured":"Kjaer SK, Dehlendorff C, Belmonte F, Baandrup L (2021) Real-world effectiveness of human papillomavirus vaccination against cervical cancer. J Natl Cancer Inst 113(10):1329\u20131335","journal-title":"J Natl Cancer Inst"},{"issue":"18","key":"6_CR37","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1056\/NEJM199210293271804","volume":"327","author":"LA Koutsky","year":"1992","unstructured":"Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM et al (1992) A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 327(18):1272\u20131278","journal-title":"N Engl J Med"},{"issue":"14","key":"6_CR38","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","volume":"383","author":"J Lei","year":"2020","unstructured":"Lei J, Ploner A, Elfstrom KM, Wang J, Roth A, Fang F et al (2020) HPV vaccination and the risk of invasive cervical cancer. N Engl J Med 383(14):1340\u20131348","journal-title":"N Engl J Med"},{"issue":"1","key":"6_CR39","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1086\/317638","volume":"183","author":"KL Liaw","year":"2001","unstructured":"Liaw KL, Hildesheim A, Burk RD, Gravitt P, Wacholder S, Manos MM et al (2001) A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis 183(1):8\u201315","journal-title":"J Infect Dis"},{"issue":"3","key":"6_CR40","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/infdis\/jiaa032","volume":"224","author":"I Man","year":"2021","unstructured":"Man I, Vanska S, Lehtinen M, Bogaards JA (2021) Human papillomavirus genotype replacement: still too early to tell? J Infect Dis 224(3):481\u2013491","journal-title":"J Infect Dis"},{"issue":"18","key":"6_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1098\/rsif.2007.0236","volume":"5","author":"M Martcheva","year":"2008","unstructured":"Martcheva M, Bolker BM, Holt RD (2008) Vaccine-induced pathogen strain replacement: what are the mechanisms? J R Soc Interface 5(18):3\u201313","journal-title":"J R Soc Interface"},{"issue":"12","key":"6_CR42","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1002\/ijc.25630","volume":"128","author":"K Matsumoto","year":"2011","unstructured":"Matsumoto K, Oki A, Furuta R, Maeda H, Yasugi T, Takatsuka N et al (2011) Predicting the progression of cervical precursor lesions by human papillomavirus genotyping: a prospective cohort study. Int J Cancer 128(12):2898\u20132910","journal-title":"Int J Cancer"},{"issue":"5","key":"6_CR43","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/cid\/ciab171","volume":"73","author":"E Meites","year":"2021","unstructured":"Meites E, Stone L, Amiling R, Singh V, Unger ER, Derkay CS et al (2021) Significant declines in juvenile-onset recurrent respiratory papillomatosis following human papillomavirus (HPV) vaccine introduction in the United States. Clin Infect Dis 73(5):885\u2013890","journal-title":"Clin Infect Dis"},{"issue":"7","key":"6_CR44","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1086\/444391","volume":"192","author":"F Mendez","year":"2005","unstructured":"Mendez F, Munoz N, Posso H, Molano M, Moreno V, van den Brule AJ et al (2005) Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines. J Infect Dis 192(7):1158\u20131165","journal-title":"J Infect Dis"},{"issue":"10","key":"6_CR45","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.3201\/eid2210.160675","volume":"22","author":"D Mesher","year":"2016","unstructured":"Mesher D, Soldan K, Lehtinen M, Beddows S, Brisson M, Brotherton JM et al (2016) Population-level effects of human papillomavirus vaccination programs on infections with nonvaccine genotypes. Emerg Infect Dis 22(10):1732\u20131740","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"6_CR46","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1111\/j.1349-7006.2011.01922.x","volume":"102","author":"S Mori","year":"2011","unstructured":"Mori S, Nakao S, Kukimoto I, Kusumoto-Matsuo R, Kondo K, Kanda T (2011) Biased amplification of human papillomavirus DNA in specimens containing multiple human papillomavirus types by PCR with consensus primers. Cancer Sci 102(6):1223\u20131227","journal-title":"Cancer Sci"},{"issue":"1","key":"6_CR47","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41479-022-00097-y","volume":"14","author":"DM Musher","year":"2022","unstructured":"Musher DM, Anderson R, Feldman C (2022) The remarkable history of pneumococcal vaccination: an ongoing challenge. Pneumonia (Nathan) 14(1):5","journal-title":"Pneumonia (Nathan)"},{"issue":"2","key":"6_CR48","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/infdis\/jix105","volume":"217","author":"D Novakovic","year":"2018","unstructured":"Novakovic D, Cheng ATL, Zurynski Y, Booy R, Walker PJ, Berkowitz R et al (2018) A prospective study of the incidence of juvenile-onset recurrent respiratory papillomatosis after implementation of a national HPV vaccination program. J Infect Dis 217(2):208\u2013212","journal-title":"J Infect Dis"},{"issue":"6","key":"6_CR49","doi-asserted-by":"publisher","first-page":"e1202","DOI":"10.1093\/infdis\/jiae209","volume":"230","author":"M Orumaa","year":"2024","unstructured":"Orumaa M, Lahlum EJ, Gulla M, Tota J, Nygard M, Nygard S (2024) Quadrivalent HPV vaccine effectiveness against cervical intraepithelial lesion grade 2 or worse in Norway: a registry-based study of 0,9 million Norwegian women. J Infect Dis 230(6):e1202\u2013e1206","journal-title":"J Infect Dis"},{"issue":"24","key":"6_CR50","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1056\/NEJMoa2201048","volume":"386","author":"JM Palefsky","year":"2022","unstructured":"Palefsky JM, Lee JY, Jay N, Goldstone SE, Darragh TM, Dunlevy HA et al (2022) Treatment of anal high-grade squamous intraepithelial lesions to prevent anal cancer. N Engl J Med 386(24):2273\u20132282","journal-title":"N Engl J Med"},{"issue":"41","key":"6_CR51","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2018.23.41.1700737","volume":"23","author":"C Patel","year":"2018","unstructured":"Patel C, Brotherton JM, Pillsbury A, Jayasinghe S, Donovan B, Macartney K et al (2018) The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent? Euro Surveill 23(41):11700737","journal-title":"Euro Surveill"},{"issue":"4","key":"6_CR52","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3390\/v16040642","volume":"16","author":"E Pesut","year":"2024","unstructured":"Pesut E, Simic I, Fures R, Milutin Gasperov N, Lez C, Feratovic F et al (2024) Monitoring HPV prevalence and risk cofactors for abnormal cytology in the post-vaccination period among Croatian women. Viruses 16(4):642","journal-title":"Viruses"},{"issue":"11","key":"6_CR53","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/j.chom.2023.10.001","volume":"31","author":"VN Pimenoff","year":"2023","unstructured":"Pimenoff VN, Gray P, Louvanto K, Eriksson T, Lagheden C, Soderlund-Strand A et al (2023) Ecological diversity profiles of non-vaccine-targeted HPVs after gender-based community vaccination efforts. Cell Host Microbe 31(11):1921\u20139.e3","journal-title":"Cell Host Microbe"},{"issue":"1","key":"6_CR54","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/path.3970","volume":"227","author":"W Quint","year":"2012","unstructured":"Quint W, Jenkins D, Molijn A, Struijk L, van de Sandt M, Doorbar J et al (2012) One virus, one lesion--individual components of CIN lesions contain a specific HPV type. J Pathol 227(1):62\u201371","journal-title":"J Pathol"},{"issue":"7","key":"6_CR55","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/jnci\/djn044","volume":"100","author":"AC Rodriguez","year":"2008","unstructured":"Rodriguez AC, Schiffman M, Herrero R, Wacholder S, Hildesheim A, Castle PE et al (2008) Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J Natl Cancer Inst 100(7):513\u2013517","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"6_CR56","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1086\/324579","volume":"184","author":"MC Rousseau","year":"2001","unstructured":"Rousseau MC, Pereira JS, Prado JC, Villa LL, Rohan TE, Franco EL (2001) Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection. J Infect Dis 184(12):1508\u20131517","journal-title":"J Infect Dis"},{"issue":"4","key":"6_CR57","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/OLQ.0000000000000731","volume":"45","author":"M Saccucci","year":"2018","unstructured":"Saccucci M, Franco EL, Ding L, Bernstein DI, Brown D, Kahn JA (2018) Non-vaccine-type human papillomavirus prevalence after vaccine introduction: no evidence for type replacement but evidence for cross-protection. Sex Transm Dis 45(4):260\u2013265","journal-title":"Sex Transm Dis"},{"key":"6_CR58","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1750-9378-4-8","volume":"4","author":"M Schiffman","year":"2009","unstructured":"Schiffman M, Clifford G, Buonaguro FM (2009) Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infect Agent Cancer 4:8","journal-title":"Infect Agent Cancer"},{"issue":"6","key":"6_CR59","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1006\/scbi.1996.0046","volume":"7","author":"JT Schiller","year":"1996","unstructured":"Schiller JT, Lowy DR (1996) Papillomavirus-like particles and HPV vaccine development. Semin Cancer Biol 7(6):373\u2013382","journal-title":"Semin Cancer Biol"},{"issue":"7","key":"6_CR60","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/S1470-2045(22)00291-1","volume":"23","author":"JZ Shing","year":"2022","unstructured":"Shing JZ, Hu S, Herrero R, Hildesheim A, Porras C, Sampson JN et al (2022) Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial. Lancet Oncol 23(7):940\u2013949","journal-title":"Lancet Oncol"},{"issue":"10","key":"6_CR61","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1002\/ijc.34850","volume":"154","author":"EA Stier","year":"2024","unstructured":"Stier EA, Clarke MA, Deshmukh AA, Wentzensen N, Liu Y, Poynten IM et al (2024) International Anal Neoplasia Society\u2019s consensus guidelines for anal cancer screening. Int J Cancer 154(10):1694\u20131702","journal-title":"Int J Cancer"},{"issue":"4","key":"6_CR62","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1086\/315805","volume":"182","author":"KK Thomas","year":"2000","unstructured":"Thomas KK, Hughes JP, Kuypers JM, Kiviat NB, Lee SK, Adam DE et al (2000) Concurrent and sequential acquisition of different genital human papillomavirus types. J Infect Dis 182(4):1097\u20131102","journal-title":"J Infect Dis"},{"issue":"11","key":"6_CR63","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1038\/s41564-022-01238-1","volume":"7","author":"G Tonkin-Hill","year":"2022","unstructured":"Tonkin-Hill G, Ling C, Chaguza C, Salter SJ, Hinfonthong P, Nikolaou E et al (2022) Pneumococcal within-host diversity during colonization, transmission and treatment. Nat Microbiol 7(11):1791\u20131804","journal-title":"Nat Microbiol"},{"issue":"4","key":"6_CR64","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/aje\/kwt018","volume":"178","author":"JE Tota","year":"2013","unstructured":"Tota JE, Ramanakumar AV, Jiang M, Dillner J, Walter SD, Kaufman JS et al (2013) Epidemiologic approaches to evaluating the potential for human papillomavirus type replacement postvaccination. Am J Epidemiol 178(4):625\u2013634","journal-title":"Am J Epidemiol"},{"issue":"1","key":"6_CR65","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1158\/1055-9965.EPI-14-0566","volume":"24","author":"JE Tota","year":"2015","unstructured":"Tota JE, Ramanakumar AV, Villa LL, Richardson H, Burchell AN, Koushik A et al (2015) Evaluation of human papillomavirus type replacement postvaccination must account for diagnostic artifacts: masking of HPV52 by HPV16 in anogenital specimens. Cancer Epidemiol Biomarkers Prev 24(1):286\u2013290","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"12","key":"6_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0166329","volume":"11","author":"JE Tota","year":"2016","unstructured":"Tota JE, Jiang M, Ramanakumar AV, Walter SD, Kaufman JS, Coutlee F et al (2016a) Epidemiologic evaluation of human papillomavirus type competition and the potential for type replacement post-vaccination. PLoS One 11(12):e0166329","journal-title":"PLoS One"},{"issue":"5","key":"6_CR67","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/infdis\/jiw215","volume":"214","author":"JE Tota","year":"2016","unstructured":"Tota JE, Ramanakumar AV, Villa LL, Richardson H, Burchell AN, Coutlee F et al (2016b) Cervical infection with vaccine-associated human papillomavirus (HPV) genotypes as a predictor of acquisition and clearance of other HPV infections. J Infect Dis 214(5):676\u2013684","journal-title":"J Infect Dis"},{"issue":"7","key":"6_CR68","doi-asserted-by":"publisher","first-page":"djw300","DOI":"10.1093\/jnci\/djw300","volume":"109","author":"JE Tota","year":"2017","unstructured":"Tota JE, Struyf F, Merikukka M, Gonzalez P, Kreimer AR, Bi D et al (2017) Evaluation of type replacement following HPV16\/18 vaccination: pooled analysis of two randomized trials. J Natl Cancer Inst 109(7):djw300","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"6_CR69","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1002\/ijc.25774","volume":"129","author":"S Vaccarella","year":"2011","unstructured":"Vaccarella S, Clifford GM, Howell-Jones R, Snijders PJ, Franceschi S, International Agency for Research on Cancer Multicentric Cervical Cancer Study Group (2011) Author\u2019s reply to: Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer 129(5):1283\u20131285","journal-title":"Int J Cancer"},{"issue":"4","key":"6_CR70","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/PAS.0000000000000342","volume":"39","author":"J van der Marel","year":"2015","unstructured":"van der Marel J, Berkhof J, Ordi J, Torne A, Del Pino M, van Baars R et al (2015) Attributing oncogenic human papillomavirus genotypes to high-grade cervical neoplasia: which type causes the lesion? Am J Surg Pathol 39(4):496\u2013504","journal-title":"Am J Surg Pathol"},{"issue":"1\u20132","key":"6_CR71","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.virol.2013.05.012","volume":"445","author":"K Van Doorslaer","year":"2013","unstructured":"Van Doorslaer K (2013) Evolution of the papillomaviridae. Virology 445(1\u20132):11\u201320","journal-title":"Virology"},{"issue":"D1","key":"6_CR72","doi-asserted-by":"publisher","first-page":"D499","DOI":"10.1093\/nar\/gkw879","volume":"45","author":"K Van Doorslaer","year":"2017","unstructured":"Van Doorslaer K, Li Z, Xirasagar S, Maes P, Kaminsky D, Liou D et al (2017) The papillomavirus episteme: a major update to the papillomavirus sequence database. Nucleic Acids Res 45(D1):D499\u2013D506","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"6_CR73","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/bjc.1991.350","volume":"64","author":"GJ van Oortmarssen","year":"1991","unstructured":"van Oortmarssen GJ, Habbema JD (1991) Epidemiological evidence for age-dependent regression of pre-invasive cervical cancer. Br J Cancer 64(3):559\u2013565","journal-title":"Br J Cancer"},{"issue":"10","key":"6_CR74","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1002\/ijc.32919","volume":"146","author":"R Venetianer","year":"2020","unstructured":"Venetianer R, Clarke MA, van der Marel J, Tota J, Schiffman M, Dunn ST et al (2020) Identification of HPV genotypes causing cervical precancer using tissue-based genotyping. Int J Cancer 146(10):2836\u20132844","journal-title":"Int J Cancer"},{"issue":"10451","key":"6_CR75","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0140-6736(24)01097-3","volume":"404","author":"F Wei","year":"2024","unstructured":"Wei F, Georges D, Man I, Baussano I, Clifford GM (2024) Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature. Lancet 404(10451):435\u2013444","journal-title":"Lancet"},{"issue":"9807","key":"6_CR76","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","volume":"378","author":"DM Weinberger","year":"2011","unstructured":"Weinberger DM, Malley R, Lipsitch M (2011) Serotype replacement in disease after pneumococcal vaccination. Lancet 378(9807):1962\u20131973","journal-title":"Lancet"},{"issue":"9","key":"6_CR77","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1002\/ijc.24528","volume":"125","author":"N Wentzensen","year":"2009","unstructured":"Wentzensen N, Schiffman M, Dunn T, Zuna RE, Gold MA, Allen RA et al (2009) Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer 125(9):2151\u20132158","journal-title":"Int J Cancer"},{"key":"6_CR78","volume":"117","author":"CM Wheeler","year":"2024","unstructured":"Wheeler CM, Adcock R, Hunt WC, Robertson M, Torrez-Martinez NE, McDonald R et al (2024) HPV genotype-specific prevalence and infection risks: a 10-year population-based study from the United States. J Natl Cancer Inst 117:djae327","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"6_CR79","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1086\/427557","volume":"191","author":"RL Winer","year":"2005","unstructured":"Winer RL, Kiviat NB, Hughes JP, Adam DE, Lee SK, Kuypers JM et al (2005) Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis 191(5):731\u2013738","journal-title":"J Infect Dis"},{"issue":"9271","key":"6_CR80","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/S0140-6736(00)04956-4","volume":"357","author":"CB Woodman","year":"2001","unstructured":"Woodman CB, Collins S, Winter H, Bailey A, Ellis J, Prior P et al (2001) Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 357(9271):1831\u20131836","journal-title":"Lancet"},{"key":"6_CR81","volume-title":"WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention","author":"World Health Organization","year":"2021","unstructured":"World Health Organization (2021) WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, 2nd edn. WHO, Geneva. https:\/\/www.who.int\/publications\/i\/item\/9789240030824. Accessed 14 Apr 2025","edition":"2"}],"container-title":["Current Topics in Microbiology and Immunology","Human Papillomavirus Epidemiology, Immunology and Cervical Cancer Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-032-17775-9_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:03:24Z","timestamp":1778598204000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-032-17775-9_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9783032177742","9783032177759"],"references-count":81,"URL":"https:\/\/doi.org\/10.1007\/978-3-032-17775-9_6","relation":{},"ISSN":["0070-217X","2196-9965"],"issn-type":[{"value":"0070-217X","type":"print"},{"value":"2196-9965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"16 February 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"EMA, AJS, and JET are employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA, and may own stock and\/or hold stock option in Merck & Co., Inc., Rahway, NJ, USA.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This chapter is a review of previously published accounts, and as such, no animal or human studies were performed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}